Ukuhlaselwa kungadluka ngaphezu kwexesha xa kushiywa kungakhange kulandelwe
I-Gout, eyaziwa nangokuthi i-arthritis e-gouty, ingahlakulela xa kukho i-acid ye-uric engaphezu komzimba. Iimpawu ziza kuphazamiseka kwaye ziqine, zibangela intlungu, ubomvu, kunye nokuvuvukala kwidibaniselwano ezichaphazelekayo, ngokuqhelekileyo uninzi lwezwane. Ukuhlaselwa kwenzeka rhoqo rhoqo ebusuku okanye ekuseni. Ukuba ukushiywa kungaphendulwanga, ukuhlaselwa rhoqo kunokukhokelela ekutheni kuhlanganyelwene kunye kunye nokunyanzeliswa kokuhamba.
Nangona ubunzima beempawu buyahlukahluka, i-gout iqhubekela phambili kwimigangatho kwaye ibuhlungu ngaphezu kwexesha. Ngokuqaphela nokuphatha iimpawu kuqala, unokuphepha ezininzi zeengxaki ezide kunye nokuphucula umgangatho wakho wobomi.
Iimpawu Zamaxesha amaninzi
Iimpawu zentsholongwane ziyahlukahluka kwisigaba sesifo. Izibambiso ezenzeka ngexesha lokuqala zihlala ziba nobumnene kwaye zilawulwa kodwa zihlala ziba nzima ngakumbi xa zingashiywanga.
Ezi zigaba zithathu zichazwe ngokubanzi ngolu hlobo lulandelayo:
- I-hyperuricemia e- Asymptomatic apho kungekho zibonakaliso kodwa i- uric acid crystals iqalisa ukwenza ifom ejikelezileyo
- I-gout ephakathi kwamanzi apho iimpawu zikhula kwaye ziphinde zibuye
- I-gout yokuphefumula engapheliyo apho i-uric acid crystals ifakwe kwi-deposit deposits, ebizwa ngokuba yi- tophi , nakwiindawo ezidibeneyo, kubangela ukuvuvukala okuqhubekayo kunye nezinye iingxaki zesikhathi eside
I-Gout yangaphakathi
Ukuhlaselwa kwe-gout ngokuqhelekileyo kuthatha iintsuku ezintathu ukuya kwi-10, kunye okanye ngaphandle kweyeza .
Nangona intlungu inokubetha ngokukhawuleza, iyanceda ukuqinisa kwinqanaba lokuqala lokuhlaselwa ngaphambi kokucombulula ngokukhawuleza. Ingxenye engaphezu kwesigama yamatyala iya kubandakanya umxube we-metatarsal-phalangeal kwisiseko sezinzwane ezinkulu. Ezinye izingosi eziqhelekileyo ziquka idolo, isangqa, isithende, i-midfoot, i-elbow, isandla kunye neminwe.
Iintlanzi ziyakwenzeka ukuba zenzeke ebusuku okanye ekuseni.
Oku kubangelwe, kwinqanaba, ukunyuka kwamanzi okuhlwa (okwandisa i-urric acid concentration) kunye namaqondo okushisa omzimba aphantsi (okukhuthaza i-uric acid crystallization).
Impawu eziqhelekileyo zokuhlaselwa kwe-gout ziquka:
- Intlungu edibeneyo kunye neyobuhlungu abanye abagulayo bayichaza ngokufana nokuphula ithambo, ukugwazwa ngeglasi, okanye ukutshisa okukhulu
- Ukuvuvukala okuhlangeneyo, ubomvu, kunye nokufudumala okubangelwa ukuvuvukala okukhulu
- Ubunzima obuhlangeneyo kunye nentlungu ngokunyakaza
- Umkhuhlane omzimba
- Ukukhathala
Ukuhlaselwa kweGout kudla rhoqo kwiiklasi xa amazinga e-uric acid aphakanyisiwe (imeko eyaziwa ngokuba yi-hyperuricemia). Ngokuqhelekileyo, iiyure ezingama-36 zokuqala ziya kuba zibuhlungu kakhulu, emva koko intlungu iya kuqala ukuphazamisa, nangona kunjalo.
Gout Topheceous Gout
I-hyperuricemia engapheliyo ingakhokelela ekwakheni ngokupheleleyo kwe-tophi phantsi kwesikhumba nakwiindawo ezidibeneyo. Ukuqokelela ezi zikhuni, i-lumpy deposits inokuphulukisa ithambo kunye ne-cartilage kwaye iholele ekuphuhlisweni kweempawu ze-arthritis ezingapheliyo.
Nangona igulane ibonakala ngokuhlaselwa ngokukhawuleza, i-arthritis engapheli ichazwa ngentlungu eqhubekayo kunye nokuvuvukala ehamba kunye nokukhathala, i-anemia, kunye nesimo sengqondo sokungahlali kakuhle. Emva kwexesha, umdibaniselwano unokukhubazeka kwaye uphazamise ukuhamba nokuhamba.
Nangona ininzi ye-tophi iya kukhula kwizinzwane ezinkulu, ezungeze iminwe, okanye kwi-tip ye-elbow, i-tophi nodules ingabonakala nantoni na emzimbeni. Kwezinye iimeko, bangene ngaphakathi kwesikhumba baze babangele iinqununu ezinjenge-chalk-like. Baye baziwa ukuba bahlakule ezindlebeni, kwiintambo zezwi, okanye nakwi-spin. Uninzi lubhekwa njengengozi ngaphandle kokuba luchaphazela ukuhamba ngokuhambelana.
Iingxaki
Amalungu kunye nesikhumba akuzona ezo zodwa ezichaphazelekayo yi-gout. Ixesha elide, ukuxilongwa kwe-hyperuricemia kungakhange kuholele ekwakheni i-crystals kwizintso nokuphuhliswa kwamatye entso .
Kwiimeko ezinzima, imeko eyaziwa njenge-acric acid i-uric acid (AUAN) ingahlakulela, ibangela ukukhubazeka kweengqondo kunye nokunciphisa ngokukhawuleza kwintsebenzo yenkunzi . Abantu abaneentsholongwane zentliziyo abangasebenzi basengozini enkulu.
Iimpawu ze-AUAN ziyakwazi ukuhluka ngokwezinga lokukhubazeka kodwa zingabandakanya:
- Ukwenyuka komchamo
- Igazi elonyukayo
- I sizathu
- Ukukhathala
- Ukuqhawukelwa ngumphefumlo
- IAnemia
- Ukukhukhuka kwamathambo (i- edema ), ngokubanzi kwimida engaphantsi
- "Iqhwa elingu-Uremic" apho urea ekhutshwe khona ngokukhupha ikhupha ikhuni
Nini ukubona iDokotela
Akuyena wonke umntu oya kugulisa iimpawu ezidakalisayo okanye afune unyango olunciphisa urate . Xa kuthethwa oko, ukuba uyayihoxisa iimpawu okanye ungaphumeleli ukuthatha inyathelo lokuphepha ukuhlaselwa, unokuphela ngokuzilimaza ixesha elide.
Ngamanye amaxesha abantu abanegalelo bacinga ukuba ukungabikho kwempawu ixesha elide kuthetha ukuba isifo sele sishiya ngokukhawuleza. Oku kudla ngokukhohlisa. Ngaphandle kokuba i-cause of dysfunction ilawulwa, isifo singakwazi ukuqhubeka sithule kwaye sivune ingozi engenakuphikiswa.
Kule nto, kufuneka ubone ugqirha ukuba:
- Oku kukuhlaselwa kwakho kokuqala. Nangona unyango olungagqitywanga, kuya kufuneka uqhubeke nokubeka esweni iziphumo zakho zegazi ukuqinisekisa ukuba unako ukugcina amazinga e-uric acid ngaphantsi kwe-6.0 mg / dL.
- Iimpawu zakho aziphuculanga emva ko-48 okanye zigcine ngaphezu kweveki. Ukuba unonyango, oku kungabonisa ukuba kufuneka kwenziwe utshintsho, kubandakanywa ukungenelela kokutya kunye nendlela yokuphila .
- Unomkhuhlane ophezulu. Nangona i-fever epholileyo ingahamba kunye nokuhlaselwa kwe-gout, i-fever ephezulu (ngaphezu kwe-100.4 F) ingaba ngumqondiso wesifo.
> Imithombo:
> Jabalameli, M .; Bagherifard, A .; Hadi, H. et al. "Gout Topherous Gout." I-QJM: I-International Journal of Medicine. 2017; 110 (4): 239-40. INGXELO: 10.1093 / qjmed / hcx019.
> Richette, P. noBarden, T. "Gout." Lancet. 2010; 375 (9711): 318-28. INGXELO: 10.1016 / S0140-6736 (09) 60883-7.
> Vargas-Santos, A. kunye neNeogi, T. "Ulawulo lweGout kunye ne-Hyperuricemia kwi-CKD." Amer J Iintsholongwane. 2017; 70 (3): 422-39. INGXELO: 10.1053 / j.ajkd.2017.01.055.